Cardior Pharmaceuticals Funding: $94M Raised, Series B
Cardior Pharmaceuticals is based in Hanover, Germany. It has raised $94M in total funding. Latest round: Series B.
Cardior Pharmaceuticals funding overview
Cardior Pharmaceuticals is based in Hanover, Germany. Cardior Pharmaceuticals has raised $94M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Cardior Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Life Sciences Partners, Boehringer Ingelheim Venture Fund, Bristol-Myers Squibb, BioMedPartners, High-Tech Gründerfonds, Inkef and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Cardior Pharmaceuticals funding
How much has Cardior Pharmaceuticals raised?
Cardior Pharmaceuticals has raised $94M in total disclosed funding across the rounds on record.
Who has invested in Cardior Pharmaceuticals?
Life Sciences Partners, Boehringer Ingelheim Venture Fund, Bristol-Myers Squibb, BioMedPartners, High-Tech Gründerfonds, Inkef are named among the investors backing Cardior Pharmaceuticals.
What was the latest Cardior Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is Cardior Pharmaceuticals based?
Cardior Pharmaceuticals is based in Hanover, Germany.
When did Cardior Pharmaceuticals last raise?
The last disclosed Cardior Pharmaceuticals round closed in January 2021 at Series B.
Round data for Cardior Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hanover and backer lists below.
